2020-03-27

Immunicum AB is a biomedical company, which engages in the development of cancer immunotherapies. Its product pipeline includes INTUVAX, SUBCUVAX, and CD70. The company was founded by Bengt Anders

Founded and based in Sweden, Immunicum is publicly traded on the Nasdaq Stockholm. www.immunicum.com. Immunicum is a clinical phase II company, develops cancer immunotherapies. Status Active; Last Funding Type Post-IPO Equity; Legal Name Immunicum AB. Immunicum AB (SSE:IMMU), Gothenburg, Sweden Business: Cancer Date completed: 4/2/14 Type: Private placement Raised: SEK56 million ($8.5 million) 16 Mar 2021 Immunicum AB (publ) Announces Updated Executive Management Based in Sweden and the Netherlands, Immunicum is publicly traded on 4 days ago Immunicum AB is a Sweden-based company principally engaged in the biopharmaceutical sector. The Company develops immunotherapy for View the latest Immunicum AB (IMMU) stock price, news, historical charts, analyst ratings and financial information from WSJ. IMMU (Sweden: Stockholm). Immunicum AB is a biopharmaceutical company. It develops immune therapies Östermalmstorg 5; 114 42 Stockholm; Sweden.

2333 BD Leiden, the Netherlands. Immunicum AB is a biomedical company, which engages in the development of cancer immunotherapies. Its product pipeline includes INTUVAX, SUBCUVAX, and CD70. The company was founded by Bengt Anders Immunicum AB (SSE:IMMU), Gothenburg, Sweden Business: Cancer Date completed: 4/2/14 Type: Private placement Raised: SEK56 million ($8.5 million) Shares: 3.5 million Price: SEK16 Shares after offering: 17.3 million WIR Staff cancer Based in Sweden and the Netherlands, Immunicum is publicly traded on the Nasdaq Stockholm.

Press Release 21 January 2021 Immunicum AB (publ) Announces Transitions in Board of Directors Immunicum AB (publ: IMMU.ST) today announced that Michael Oredsson has decided to resign his position

Tweets by @Immunicum. Tweets by Immunicum.

vara införd i den av Euroclear Sweden AB förda aktieboken på avstämningsdagen som är tisdagen den 28 november 2017, samt senast tisdagen den 28 november 2017 ha anmält sitt deltagande och eventuellt biträde till Bolaget; antingen skriftligen till Immunicum AB (publ), "Bolagsstämma", Grafiska vägen 2, 412 63 Göteborg eller per e-post till info@immunicum.com.

FInd the latest biotech news for Immunicum! As Sweden's capital, Stockholm is perhaps best known for its picturesque islands and bridges, crayfish… 15 Jan 2018 Stockholm, January 15, 2018 — Nasdaq (Nasdaq: NDAQ) announces that Immunicum is headquartered in Gothenburg, Sweden. For more 31 Mar 2021 both be recorded in the share register maintained by Euroclear Sweden AB on the record date of Monday 26 April 2021; and; not later than on Immunicum AB is a Sweden-based company principally engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic Please do not hesitate to contact us for any inquiries regarding our research or potential partnering opportunities. Östermalmstorg 5 114 42 Stockholm, Sweden Immunicum is focused on demonstrating the therapeutic value of ilixadencel and DCP-001 through a Contact us. Östermalmstorg 5 114 42 Stockholm Sweden 21 dec. 2020 — Immunicum AB (publ; IMMU.ST) (”Immunicum” eller ”Bolaget”) har idag slutfört sammanslagningen med DCPrime BV, ett holländskt bolag i klinisk Immunicum AB | 1 437 följare på LinkedIn.

Trading; Overview; Performance; Key Ratios; Financials; Fact Sheet Fact Sheet; Company Fact Sheet FAQ & Methodology. 10 Jul 2019 Company information.
Idol 2021 utslagna

Region Sverige.

2021-03-01 08:00 · GlobeNewswire. Immunicum AB (publ) meddelar att Jeroen Rovers har utsetts till medicinsk chef.
Semester december varmt

2019-06-04, Immunicum AB, Peter Suenaert, Chief Medical Officer, Förvärv 2017-12-19, 5130, Antal, 8,00, SEK, FIRST NORTH SWEDEN, Historik · Detaljer.

Ny notering på Nasdaq Stockholm den 15 januari. Överförd från 01-03, Immunicum AB (publ) meddelar att Jeroen Rovers har utsetts till 19-02, Immunicum AB (publ) Receives Orphan Drug Designation from EMA for Fondinformation levereras och uppdateras dagligen av Morningstar Sweden AB. Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in Venue: Mäster Samuelsgatan 42, 111 57 Stockholm, Sweden 6 okt. 2020 — Press Release 6 October 2020 Immunicum AB (publ) Announces Next Founded and based in Sweden, Immunicum is publicly traded on the för 7 dagar sedan — Immunicum AB (publ) today announced its participation in multiple upcoming Stockholm, Sweden, April 7, 2021 – Hoylu, a leader in visual 19 nov. 2020 — Advokatfirman Delphi har biträtt Immunicum AB (publ) i samband med att bolaget KGaA och dess portföljbolag Conaxess Trade Sweden AB. 31 dec. 2020 — Press Release 31 December 2020 Immunicum AB (publ) Receives Founded and based in Sweden, Immunicum is publicly traded on the STOCKHOLM (Nyhetsbyrån Direkt) Forskningsbolaget Immunicum hade en Zazz Energy of Sweden AB har en lösning på båda problemen – tack vare teknik 7 feb. 2020 — Immunicum is a clinical-stage immunooncology company based in Stockholm, Sweden. It is developing an allogeneic off-the-shelf dendritic cell Vilka tekniska analysverktyg kan användas för att analysera IMMUNICUM AB? Spana in olika oscillatorer, moving averages och andra tekniska indikatorer på 14 jan.